EMPOWERING ACCESS. ENABLING INNOVATION.
Vetex Pharma is a Hong Kong–based pharmaceutical solutions company dedicated to bridging the gap between cutting-edge active pharmaceutical ingredients (APIs), regulatory intelligence, and global healthcare access. Founded with the vision of becoming a trusted link in the pharmaceutical value chain, we specialize in the sourcing, registration, and strategic supply of APIs, advanced intermediates, and specialty molecules from GMP-certified global partners.
We are a pharmaceutical enabler, connecting marketing authorization holders (MAHs), biotech innovators, distributors, and hospital networks with the best-in-class pharmaceutical products.
Our Global Footprint
From our headquarters in Hong Kong, Vetex Pharma operates a growing network of strategic offices and partners across Asia, Europe, the Middle East, and Latin America. This enables us to source from audited suppliers in India, China, Europe, and Korea while delivering regulatory-ready solutions to over 30+ international markets.
Zero-Manufacturing, Full Control
We work exclusively with GMP-certified, regulatory-audited manufacturers, enabling our clients to access high-quality APIs and dossiers — without the burden of owning production assets.
Regulatory Excellence
We provide full support for DMF, CEP, WC, CTD dossiers, and registration pathways, helping clients fast-track product approvals and market entry.
Therapeutic Precision
Our product focus spans oncology, CNS, cardiovascular, anti-infectives, metabolic disorders, and peptide/oligonucleotide platforms.
Flexible Business Models
Whether it’s exclusive licensing, territory-specific supply, or white-labeled formulations, we adapt to your strategy.
